HALE DAVID F — SEC Form 4 filings

SEC reporting owner CIK 1024004. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-27 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oncternal Therapeutics, Inc. (ONCT)Director22 legs · 980 sh · $8,8591
Dermata Therapeutics, Inc. (DRMA)Director34

Form 4 filings — HALE DAVID F

FiledFormIssuerReported transactionsSource
2026-01-064Dermata Therapeutics, Inc. (DRMA)Grant/award (A): 2,500 (derivative) @ $0EDGAR
2025-01-234Dermata Therapeutics, Inc. (DRMA)Grant/award (A): 78,741 · Grant/award (A): 78,741 (derivative)EDGAR
2025-01-144Dermata Therapeutics, Inc. (DRMA)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2024-06-244Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 3,300 (derivative) @ $0EDGAR
2024-02-274Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 714 @ $9.04 · Purchase (P): 266 @ $9.04EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1024004 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →